Coxsackieviruses are non-enveloped viruses belonging to the picornaviridae family and enterovirus genus that possess linear single-stranded RNA as their genetic material. Based on their pathogenecity tested on mice, they are further categorized into group A and group B viruses. Group A viruses are known to cause skin and mucous membrane infections leading to disorders such as herpangina, hand-foot-and-mouth (HFM) disease and acute hemorrhagic conjunctivitis (AHC), whereas, group B viruses infect the pancreas, liver and heart leading to various conditions such as pericarditis, hepatitis, myocarditis and pleurodynia.
For Any Queries Get Solutions With A PDF Sample : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1481
According to the estimations of Centers for Disease Control and Prevention (CDC), out of all the neonatal enterovirus infections from the year 1983 – 2003, coxsackievirus infections accounted for around 25% share. People from all age groups get infected by coxsackievirus but children are more susceptible to infection. Fetuses or newborns are at a high risk of infection if their mother gets infected during pregnancy. These viruses are found in the feces, fluid in blisters, nasal secretions and saliva of infected patients.
Patients infected with coxsackievirus are diagnosed by the appearance of blisters on the hands, mouth and feet. In rare instances, viral identification tests can be performed that involves the use of real time-PCR for amplification of the DNA sample. This type of test distinguishes the virus at the genus, species and subtype level of nomenclature. Tylenol (acetaminophen) is usually administered for symptomatic treatment to reduce fever; other treatment options include Benadryl (diphenhydramine). The coxsackievirus diagnostics market can be segmented on the basis of the type of diagnostic tests performed in various hospitals, private laboratories, etc., instrumentation and geography.
The major factors driving the growth of this market are increasing incidence of coxsackievirus infections, increased awareness among the public and rigorous government initiatives to reduce the incidences of these infections. Lack of resources and accessibility in remote areas is one of the key factors that may mask the growth of this market. Some of the leading players in this market include Abbott Laboratories, Danaher Corporation, Affymetrix, Inc., Bio-Rad Laboratories, Inc. and Hologic Corporation.
View exclusive Global strategic Business report : http://www.transparencymarketresearch.com/coxsackievirus-diagnostics-market.html
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Rest of the World
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research
90 State Street,
NY – 12207
USA – Canada Toll Free 866-552-3453